Gastric carcinoid tumors

Journal of Surgical Oncology

Volumn 93, Issue 5, 2006, Pages 347-349

  Stilo, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; OCTREOTIDE; STOMACH SECRETION INHIBITOR; GASTRIN;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER SURGERY; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ENDOSCOPIC SURGERY; GASTROINTESTINAL ENDOSCOPY; HUMAN; PRIORITY JOURNAL; STOMACH CARCINOID; STOMACH SURGERY; TYPE 1 STOMACH CARCINOID; TYPE 2 STOMACH CARCINOID; TYPE 3 STOMACH CARCINOID; BLOOD; CARCINOID; CLASSIFICATION; FEMALE; MALE; PATHOPHYSIOLOGY; PROGNOSIS; STOMACH TUMOR;

CARCINOID TUMOR; FEMALE; GASTRINS; HUMANS; MALE; PROGNOSIS; STOMACH NEOPLASMS;

EID: 33646171346     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20469     Document Type: Editorial

References (16)

1. Rindi G, Luinetti O, Cornaggia M, et al.: Three subtypes of gastric argyriphil carcinoid and the gastric neuroendocrine carcinoma: Clinicopathologic study. Gastroenterology 1993;104:994-1006.
2. Solcia E, Fiocca R, Sessa F, et al.: Morphology and natural history of gastric endocrine tumors. In: Hakanson R, Sundler F, editors. The stomach as an endocrine organ. Amsterdam: Elsevier; 1991. 473-498.
3. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
4. Godwin JD: Carcinoid tumors: An analysis of 2837 cases. Cancer 1975;49:560-569.
5. Voutilainen M, Juhola M, Patkänen R, et al.: Immunohistochemical study of neuroendocrine cells at the gastric cardia mucosa. J Clin Pathol 2002;55:767-769.
6. Bordi C, Yu JY, Baggi MT, et al.: Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 1991;67:663-672.
7. Rindi G, Bordi C, Rappel S, et al.: Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World J Surg 1996;20:169-172.
8. Ji-Yao Yu, Lu-Ping W, Yu-Hong M, et al.: Classification of gastric neuroendocrine tumors and its clinicopathologic significance. World J Gastroenterol 1998;4:158-161.
9. Solcia E, Rindi G, Larosa S, et al.: Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Microsc Res Tech 2000;48:339-348.
10. Tomassetti P, Campana D, Piscitelli L, et al.: Treatment of Zollinger-Ellison Syndrome. World J Gastroenterol 2005;11:5423-5432.
11. Schindl M, Kaserer K, Niederle B: Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment. Arch Surg 2001;136:49-54.
12. Rorstad O: Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol 2005;89:151-160.
13. Gilligan CJ, Lawton GP, Tang LH, et al.: Gastric carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion. Am J Gastronenterol 1995;90:338-352.
14. Leong WL, Pasieka JL: Regression of metastatic carcinoid tumors with octeotride therapy. Two reports and a review of the literature. J Surg Oncol 2002;79:180-187.
15. Jordan PH, Barroso A, Sweeney J: Gastric carcinoids in patients with hypergastrinemia. J Am Coll Surg 2005;199:552-555.
16. Delle Fave G, Capurso G, Milone M, et al.: Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol 2005;19:659-673.